Jörg Heineke

1.8k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Jörg Heineke is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Jörg Heineke has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cancer Research. Recurrent topics in Jörg Heineke's work include Signaling Pathways in Disease (3 papers), Fibroblast Growth Factor Research (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Jörg Heineke is often cited by papers focused on Signaling Pathways in Disease (3 papers), Fibroblast Growth Factor Research (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Jörg Heineke collaborates with scholars based in Germany, United States and Switzerland. Jörg Heineke's co-authors include Kai C. Wollert, Helmut Drexler, Tibor Kempf, Christian Willenbockel, Jeffery D. Molkentin, Jian Xu, Matthias Eden, Jens Strelau, Hans W.M. Niessen and Daniel Kotlarz and has published in prestigious journals such as Circulation, Circulation Research and International Journal of Molecular Sciences.

In The Last Decade

Jörg Heineke

15 papers receiving 1.4k citations

Hit Papers

The Transforming Growth F... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Heineke Germany 11 536 468 440 370 296 15 1.4k
Shinya Kaname Japan 22 138 0.3× 435 0.9× 192 0.4× 131 0.4× 430 1.5× 94 1.6k
Michelle J. Ormseth United States 20 178 0.3× 368 0.8× 373 0.8× 107 0.3× 185 0.6× 42 1.1k
Arja Pasternack Finland 25 165 0.3× 683 1.5× 217 0.5× 233 0.6× 104 0.4× 73 1.6k
Roslynn A. Stirzaker United States 8 263 0.5× 555 1.2× 122 0.3× 171 0.5× 848 2.9× 8 1.8k
Christian Widera Germany 15 570 1.1× 817 1.7× 379 0.9× 417 1.1× 335 1.1× 23 1.8k
Djuro Kosanovic Germany 22 272 0.5× 378 0.8× 58 0.1× 196 0.5× 179 0.6× 62 1.4k
Mária Filková Czechia 20 105 0.2× 422 0.9× 518 1.2× 165 0.4× 330 1.1× 49 1.5k
Jurjan Aman Netherlands 18 178 0.3× 250 0.5× 70 0.2× 71 0.2× 143 0.5× 62 1.1k
M Koss United States 18 192 0.4× 233 0.5× 310 0.7× 159 0.4× 105 0.4× 28 1.5k
Jay Tuttle United States 16 171 0.3× 204 0.4× 54 0.1× 212 0.6× 336 1.1× 40 1.1k

Countries citing papers authored by Jörg Heineke

Since Specialization
Citations

This map shows the geographic impact of Jörg Heineke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Heineke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Heineke more than expected).

Fields of papers citing papers by Jörg Heineke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Heineke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Heineke. The network helps show where Jörg Heineke may publish in the future.

Co-authorship network of co-authors of Jörg Heineke

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Heineke. A scholar is included among the top collaborators of Jörg Heineke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Heineke. Jörg Heineke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Most, Patrick, Martin Busch, Jörg Heineke, et al.. (2022). Chronic heart failure as a sequel after severe burn injury – First insight into a novel pathological heart-skin axis. Journal of Molecular and Cellular Cardiology. 173. S72–S73. 1 indexed citations
2.
Heineke, Jörg, Carolina De La Torre, Beate Fißlthaler, et al.. (2021). NFAT5/TonEBP Limits Pulmonary Vascular Resistance in the Hypoxic Lung by Controlling Mitochondrial Reactive Oxygen Species Generation in Arterial Smooth Muscle Cells. Cells. 10(12). 3293–3293. 8 indexed citations
3.
Nicin, Luka, Wesley Abplanalp, Badder Kattih, et al.. (2020). Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. European Heart Journal. 41(19). 1804–1806. 206 indexed citations
4.
Richter, Beatrice, Anja Rahn, Dagmar‐Christiane Fischer, et al.. (2019). FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis. International Journal of Molecular Sciences. 20(18). 4634–4634. 74 indexed citations
5.
Thackeray, James T., Britta Stapel, Melanie Ricke‐Hoch, et al.. (2017). Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression. JCI Insight. 2(10). 31 indexed citations
7.
Wang, Yong, Bruno Galy, Mortimer Korf‐Klingebiel, et al.. (2016). Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. European Heart Journal. 38(5). ehw333–ehw333. 141 indexed citations
8.
Hartmann, Dorothee, Jan Fiedler, Kristina Sonnenschein, et al.. (2016). MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease. Circulation. 134(24). 1973–1990. 43 indexed citations
9.
Breitbart, Astrid, Florian Brandes, Oliver J. Müller, et al.. (2013). Abstract 182: CTRP9 - A Novel Cardiac Derived Secreted Factor With Anti-hypertrophic Properties. Circulation Research. 113(suppl_1). 3 indexed citations
10.
Echtermeyer, Frank, Christine Herzog, Martin J. Mueller, et al.. (2011). Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling. Cardiovascular Research. 92(1). 123–131. 40 indexed citations
11.
Korf‐Klingebiel, Mortimer, Tibor Kempf, Klaus‐Dieter Schlüter, et al.. (2011). Conditional Transgenic Expression of Fibroblast Growth Factor 9 in the Adult Mouse Heart Reduces Heart Failure Mortality After Myocardial Infarction. Circulation. 123(5). 504–514. 55 indexed citations
12.
Kempf, Tibor, Matthias Eden, Jens Strelau, et al.. (2006). The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury. Circulation Research. 98(3). 351–360. 517 indexed citations breakdown →
13.
Heineke, Jörg, Tibor Kempf, Theresia Kraft, et al.. (2003). Downregulation of Cytoskeletal Muscle LIM Protein by Nitric Oxide. Circulation. 107(10). 1424–1432. 60 indexed citations
14.
Wollert, Kai C., Beate Fiedler, Stepan Gambaryan, et al.. (2002). Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes. Hypertension. 39(1). 87–92. 121 indexed citations
15.
Wollert, Kai C., Jörg Heineke, Jürgen Westermann, et al.. (2000). The Cardiac Fas (APO-1/CD95) Receptor/Fas Ligand System. Circulation. 101(10). 1172–1178. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026